Anna Gaulton

Active 2002–2023

47
Papers
23,066
Citations
34
h-index
44
i10-index

Citations

Citations per year for Anna Gaulton1896: 1 citations1911: 1 citations1966: 1 citations1967: 1 citations1973: 1 citations1988: 2 citations1993: 2 citations1995: 1 citations1996: 1 citations1998: 4 citations1999: 2 citations2000: 6 citations2002: 9 citations2003: 31 citations2004: 25 citations2005: 26 citations2006: 25 citations2007: 29 citations2008: 23 citations2009: 22 citations2010: 17 citations2011: 49 citations2012: 125 citations2013: 210 citations2014: 237 citations2015: 327 citations2016: 344 citations2017: 423 citations2018: 548 citations2019: 925 citations2020: 1,176 citations2021: 1,340 citations2022: 1,141 citations2023: 1,125 citations2024: 1,471 citations2025: 1,107 citations2026: 220 citations1897–1910: no citations, so these years are not shown1912–1965: no citations, so these years are not shown1968–1972: no citations, so these years are not shown1974–1987: no citations, so these years are not shown1989–1992: no citations, so these years are not shown1994: no citations, so this year is not shown1997: no citations, so this year is not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,759 citing papers, 18.4% of this breakdownChina: 1,967 citing papers, 13.1% of this breakdownUnited Kingdom: 1,312 citing papers, 8.7% of this breakdownGermany: 1,033 citing papers, 6.9% of this breakdownIndia: 517 citing papers, 3.4% of this breakdownSwitzerland: 511 citing papers, 3.4% of this breakdownFrance: 435 citing papers, 2.9% of this breakdownItaly: 409 citing papers, 2.7% of this breakdownCanada: 397 citing papers, 2.6% of this breakdownSpain: 396 citing papers, 2.6% of this breakdownJapan: 362 citing papers, 2.4% of this breakdownSweden: 357 citing papers, 2.4% of this breakdown
0%18.4%Other 30.5%

Fields

  • Computer Science49%
  • Biochemistry, Genetics and Molecular Biology26.8%
  • Medicine12.3%
  • Materials Science3%
  • Chemistry1.9%
  • Immunology and Microbiology1.2%
  • Other5.8%

Topics

  • Computational Drug Discovery Methods19.9%
  • Machine Learning in Materials Science5.3%
  • Bioinformatics and Genomic Networks5.3%
  • Protein Structure and Dynamics4%
  • Microbial Natural Products and Biosynthesis2.3%
  • Receptor Mechanisms and Signaling2.2%
  • Other61%

Coauthors

All papers

Open in search
  1. ChEMBL: a large-scale bioactivity database for drug discovery

    Authors: , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2011 cited by 4,451

  2. ChEMBL: towards direct deposition of bioassay data

    Authors: , , , , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2018 cited by 2,418

  3. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods

    Authors: , , , , , , , , , , , , , , , , , , , - Nucleic Acids Research 2023 cited by 1,203

  4. A comprehensive map of molecular drug targets

    Authors: , , , , , , , , , , - Nature Reviews Drug Discovery 2016 cited by 2,455

  5. The ChEMBL database in 2017

    Authors: , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2016 cited by 2,414

  6. An open source chemical structure curation pipeline using RDKit

    Authors: , , , , , , , , - Journal of Cheminformatics, J. Cheminformatics 2020 cited by 715

  7. ChEMBL web services: streamlining access to drug discovery data and utilities

    Authors: , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2015 cited by 789

  8. The Global Phosphorylation Landscape of SARS-CoV-2 Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maya Modak, Diego Quintero, Yuan Zhou, Aurélien Dugourd, Alberto Valdeolivas, Trupti Patil, Qiongyu Li, Ruth Hüttenhain, Merve Çakır, Monita Muralidharan, Minkyu Kim, Gwendolyn Μ. Jang, Beril Tutuncuoglu, Joseph Hiatt, Jeffrey Guo, Jiewei Xu, Sophia Bouhaddou, Christopher J.P. Mathy, Anna Gaulton, Emma J. Manners, Eloy Félix, Ying Shi, Marisa Goff, Jean K. Lim, Timothy McBride, Michael C. O’Neal, Yiming Cai, Jason C. Chang, David Broadhurst, Saker Klippsten, Emmie de Wit, Andrew R. Leach, Tanja Kortemme, Brian K. Shoichet, Mélanie Ott, Julio Sáez-Rodríguez, Benjamin R. tenOever, R. Dyche Mullins, Elizabeth R. Fischer, Georg Kochs, Robert Grosse, Adolfo García‐Sastre, Marco Vignuzzi, Jeffery R. Johnson, Kevan M. Shokat, Danielle L. Swaney, Pedro Beltrão, Nevan J. Krogan - Cell 2020 cited by 1,157

  9. The ChEMBL bioactivity database: an update

    Authors: , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2013 cited by 1,548

  10. Open Targets: a platform for therapeutic target identification and validation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johanna R. McEntyre, Alfonso Muñoz-Pomer Fuentes, Claire O'Donovan, Irene Papatheodorou, Helen E. Parkinson, Barbara Palka, Justin E. Paschall, Robert Petryszak, Naruemon Pratanwanich, Sirarat Sarntivijai, Gary Saunders, Konstantinos Sidiropoulos, Thomas Smith, Zbyslaw Sondka, Oliver Stegle, Y. Amy Tang, Edward Turner, Brendan W. Vaughan, Olga Vrousgou, Xavier Watkins, Maria Jesus Martin, Philippe Sanseau, Jessica Vamathevan, Ewan Birney, Jeffrey Barrett, Ian Dunham - Nucleic Acids Research, Nucleic Acids Res. 2016 cited by 529

  11. SureChEMBL: a large-scale, chemically annotated patent document database

    Authors: , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2015 cited by 241

  12. Unexplored therapeutic opportunities in the human genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 cited by 385

  13. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristine E. Lynch, Scott L. DuVall, Helene Garcon, Lauren O. Thomann, Jin Zhou, Bryan R. Gorman, Jennifer E. Huffman, Christopher J. O’Donnell, Philip S. Tsao, Jean C. Beckham, Saiju Pyarajan, Sumitra Muralidhar, Grant D. Huang, Rachel Ramoni, Pedro Beltrão, John Danesh, Adriana M. Hung, Kyong‐Mi Chang, Yan V. Sun, Jacob Joseph, Andrew R. Leach, Todd L. Edwards, Kelly Cho, J. Michael Gaziano, Adam S. Butterworth, Juan P. Casas, VA Million Veteran Program COVID-19 Science Initiative - Nature Medicine 2021 cited by 247

  14. Pharos: Collating protein information to shed light on the druggable genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2016 cited by 318

  15. Improving the odds of drug development success through human genomics: modelling study

    Authors: , , , , , , , , , , , , - Scientific Reports 2019 cited by 272

  16. Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies

    Authors: , , , , , , - Journal of Medicinal Chemistry 2021 cited by 139

  17. Erratum: Unexplored therapeutic opportunities in the human genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 cited by 323

  18. UniChem: a unified chemical structure cross-referencing and identifier tracking system

    Authors: , , , , , , , , , - Journal of Cheminformatics, J. Cheminformatics 2013 cited by 182

  19. Activity, assay and target data curation and quality in the ChEMBL database

    Authors: , , , - Journal of Computer-Aided Molecular Design, J. Comput. Aided Mol. Des. 2015 cited by 177

  20. Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery

    Authors: , , , , , - Journal of Cheminformatics, J. Cheminformatics 2019 cited by 172

  21. The druggable genome and support for target identification and validation in drug development

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2016 cited by 1,030

  22. The EBI RDF platform: linked open data for the life sciences

    Authors: , , , , , , , , , , , , , , , - Bioinformatics, Bioinform. 2014 cited by 249

  23. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.

    Authors: , , , , , - 2017 cited by 66

  24. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 30